Takeda Pharmaceutical
TAK
#478
Rank
โ‚น4.297 T
Marketcap
โ‚น1,292
Share price
0.77%
Change (1 day)
15.63%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น4.456 Trillion

According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are โ‚น4.456 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31โ‚น4.168 T-3.37%
2024-03-31โ‚น4.314 T-7.9%
2023-03-31โ‚น4.684 T0.25%
2022-03-31โ‚น4.672 T-8.61%
2021-03-31โ‚น5.112 T-9.84%
2020-03-31โ‚น5.670 T5.33%
2019-03-31โ‚น5.383 T320.82%
2018-03-31โ‚น1.279 T-8.47%
2017-03-31โ‚น1.397 T30.91%
2016-03-31โ‚น1.067 T-1.59%
2015-03-31โ‚น1.084 T-7.98%
2014-03-31โ‚น1.179 T19.47%
2013-03-31โ‚น986.90 B11.82%
2012-03-31โ‚น882.57 B154.74%
2011-03-31โ‚น346.46 B10.71%
2010-03-31โ‚น312.95 B-13.52%
2009-03-31โ‚น361.85 B75.35%
2008-03-31โ‚น206.36 B-7.93%
2007-03-31โ‚น224.15 B-15.12%
2006-03-31โ‚น264.07 B20.17%
2005-03-31โ‚น219.76 B-5.23%
2004-03-31โ‚น231.89 B16.82%
2003-03-31โ‚น198.49 B-0.56%
2002-03-31โ‚น199.61 B8.9%
2001-03-31โ‚น183.29 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚น10.204 T 128.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น5.934 T 33.16%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
โ‚น10.393 T 133.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.620 T 26.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
โ‚น97.41 B-97.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
โ‚น182.02 B-95.92%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
โ‚น7.237 T 62.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น5.508 T 23.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น6.978 T 56.57%๐Ÿ‡บ๐Ÿ‡ธ USA